Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 225

1.

Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: evidence for independent mechanisms of caspase activation.

Landowski TH, Shain KH, Oshiro MM, Buyuksal I, Painter JS, Dalton WS.

Blood. 1999 Jul 1;94(1):265-74.

PMID:
10381522
[PubMed - indexed for MEDLINE]
Free Article
2.

Selection for drug resistance results in resistance to Fas-mediated apoptosis.

Landowski TH, Gleason-Guzman MC, Dalton WS.

Blood. 1997 Mar 15;89(6):1854-61.

PMID:
9058704
[PubMed - indexed for MEDLINE]
Free Article
3.

The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.

Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.

Cell Death Differ. 1998 Sep;5(9):735-42.

PMID:
10200532
[PubMed - indexed for MEDLINE]
Free Article
4.

The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.

Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM.

Cancer Res. 1997 Sep 1;57(17):3823-9.

PMID:
9288794
[PubMed - indexed for MEDLINE]
Free Article
5.

Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).

Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM.

Blood. 1997 Oct 15;90(8):3118-29.

PMID:
9376593
[PubMed - indexed for MEDLINE]
Free Article
6.

Molecular determinants of apoptosis induced by cytotoxic drugs.

Fulda S, Friesen C, Debatin KM.

Klin Padiatr. 1998 Jul-Aug;210(4):148-52.

PMID:
9743944
[PubMed - indexed for MEDLINE]
7.

Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line.

Shain KH, Landowski TH, Buyuksal I, Cantor AB, Dalton WS.

Leukemia. 2000 May;14(5):830-40.

PMID:
10803514
[PubMed - indexed for MEDLINE]
8.

Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS.

Blood. 1999 Mar 1;93(5):1658-67.

PMID:
10029595
[PubMed - indexed for MEDLINE]
Free Article
9.

Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation.

Bian X, Giordano TD, Lin HJ, Solomon G, Castle VP, Opipari AW Jr.

J Biol Chem. 2004 Feb 6;279(6):4663-9. Epub 2003 Nov 14.

PMID:
14617634
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.

Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM.

Oncogene. 2001 Mar 1;20(9):1063-75.

PMID:
11314043
[PubMed - indexed for MEDLINE]
Free Article
12.

IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.

Tietze MK, Wuestefeld T, Paul Y, Zender L, Trautwein C, Manns MP, Kubicka S.

Cancer Gene Ther. 2000 Oct;7(10):1315-23.

PMID:
11059688
[PubMed - indexed for MEDLINE]
Free Article
13.

Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide.

Tu Y, Xu FH, Liu J, Vescio R, Berenson J, Fady C, Lichtenstein A.

Blood. 1996 Sep 1;88(5):1805-12.

PMID:
8781438
[PubMed - indexed for MEDLINE]
Free Article
14.

Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.

Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O.

Cancer Res. 2000 Jun 1;60(11):2912-8.

PMID:
10850437
[PubMed - indexed for MEDLINE]
Free Article
15.

Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.

Uslu R, Borsellino N, Frost P, Gárban H, Ng CP, Mizutani Y, Belldegrun A, Bonavida B.

Clin Cancer Res. 1997 Jun;3(6):963-72.

PMID:
9815772
[PubMed - indexed for MEDLINE]
Free Article
16.

Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.

Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.

Cancer Res. 2003 Jan 15;63(2):513-21.

PMID:
12543810
[PubMed - indexed for MEDLINE]
Free Article
17.

Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.

Evens AM, Prachand S, Shi B, Paniaqua M, Gordon LI, Gartenhaus RB.

Clin Cancer Res. 2004 Feb 15;10(4):1481-91.

PMID:
14977852
[PubMed - indexed for MEDLINE]
Free Article
18.

Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.

Wrone-Smith T, Izban KF, Ergin M, Cosar EF, Hsi ED, Alkan S.

Exp Hematol. 2001 May;29(5):572-81.

PMID:
11376869
[PubMed - indexed for MEDLINE]
19.

Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.

Spierings DC, de Vries EG, Vellenga E, de Jong S.

Cell Death Differ. 2003 Jul;10(7):808-22.

PMID:
12815464
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk